Workout
Healthy Eating
Meditation
Recipe
Beauty Tips
Social Service
About Us
Review Board
Editorial Process
Contact Us
Health Tracker
AI Tools
✔Fact Checked

Sprinter Jakobsen Steps Down in Twelfth Stage of Tour De France

Fabio Jakobsen has abandoned the Tour de France early in the twelfth stage.

The sprinter had to let the peloton go early and saw his deficit quickly increase to more than five minutes. His team leaders encouraged him from the car, but Jakobsen decided to end the suffering after 25 kilometers.

YouTube video

Sprinter Jakobsen Steps Down in Twelfth Stage of Tour De France.

Jakobsen was the trump card for the mass sprints at his team dsm-firmenich PostNL, but could not live up to expectations. The 27-year-old sprinter, who won a Tour stage in 2022, did not get further than a fifth and seventh place. On Wednesday he finished 168th and last in the tough stage to Le Lioran.

Tough mountain stages.

In the tough mountain stages Jakobsen always had a hard time. With the help of his teammates he did finish within the time limit, but in the ranking he occupied the last place.

The twelfth stage of the Tour goes from Aurillac to Villeneuve-sur-Lot. On paper, there is a chance for the sprinters, but the peloton will have to deal with a lot of altitude, with three categorized climbs.

Last reviewed on

Expert Q&A
Ask a Question
Share Now:

Was this article helpful?

🤓

😕

dotdash removebg preview 1

Verywel Fit is part of the Dotdash Meredith publishing family.

Please review our updated Terms of Service.

logo

The best of health & fitness platform

We do the research so you don't have to. Stay up-to-date with the latest health and fitness information.

We don’t spam! Read our privacy policy for more info.

The Verywel Fit News team takes pride in providing readers with accurate, properly sourced, and objectively analyzed content. Each news piece is stringently fact-checked by our Integrity Network, and any form of plagiarism or malicious behavior from our authors and contributors is strictly forbidden.

Our articles follow a number of key standards:

  • Each cited research and studies should come from renowned peer-reviewed journals or educational bodies. Additionally, any quoted data and figures must be traceable to its origin, while also detailing their significance.

  • Content related to treatment, medicine, and procedure must plainly specify availability, cost, possible side effects, targets, possible interactions, and unapproved usage (if relevant).

  • Every news article should have inputs from at least two authorized professionals, with corresponding qualifications and ties to appropriate associations or works.

  • The reader must be made aware of any potential conflict of interest relating to the source or study.

  • Finally, all news pieces should be supplied with enough background and context regarding the relevant topic or condition.